• Albania Albania
  • Argentina Argentina
  • Australia Australia
  • Austria Austria
  • Belarus Belarus
  • Belgium Belgium
  • Brazil Brazil
  • Bulgaria Bulgaria
  • Canada Canada
  • Chile Chile
  • China China
  • Colombia Colombia
  • Costa Rica Costa Rica
  • Croatia Croatia
  • Czech Republic Czech Republic
  • Denmark Denmark
  • Egypt Egypt
  • Estonia Estonia
  • Finland Finland
  • France France
  • Georgia Georgia
  • Germany Germany
  • Greece Greece
  • Hong Kong Hong Kong
  • Hungary Hungary
  • India India
  • Indonesia Indonesia
  • Ireland Ireland
  • Israel Israel
  • Italy Italy
  • Japan Japan
  • Kazakhstan Kazakhstan
  • Korea Korea
  • Latvia Latvia
  • Lithuania Lithuania
  • Luxembourg Luxembourg
  • Mexico Mexico
  • Montenegro Montenegro
  • Morocco Morocco
  • Myanmar Myanmar
  • Netherlands Netherlands
  • New Zealand New Zealand
  • Norway Norway
  • Pakistan Pakistan
  • Panama Panama
  • Peru Peru
  • Philippines Philippines
  • Poland Poland
  • Portugal Portugal
  • Qatar Qatar
  • Romania Romania
  • Russia Russia
  • Saudi Arabia Saudi Arabia
  • Serbia Serbia
  • Singapore Singapore
  • Slovakia Slovakia
  • South Africa South Africa
  • Spain Spain
  • Sweden Sweden
  • Taiwan Taiwan
  • Thailand Thailand
  • Turkey Turkey
  • Ukraine Ukraine
  • United Arab Emirates United Arab Emirates
  • United Kingdom United Kingdom
  • United States United States
  • Vietnam Vietnam

Boston's Next Biotech Hub

Author: Aaron Jodka

By Aaron Jodka | JUNE 2019

Greater Boston’s thriving life science industry has spurred a lot of debate about its next biotech hub. Several viable candidates range from Allston, with King Street’s NEXUS at The Allston Innovation Corridor and Harvard’s campus expansion, to Somerville and numerous suburban communities already attracting growth. However, Boston’s A Street Corridor is taking the lead.

A Street CorridorFoundation Medicine (Roche subsidiary) is said to be close to a massive lease of up to 900,000 SF at Seaport Square, topping the recent Sanofi deal at Cambridge Crossing in size. Meanwhile, the heavy land investment in the Seaport area has really caught our attention. Anchor Line Partners, along with Alexandria Real Estate Equities, has its sights set on a 210,000 SF life science building on A Street. Alexandria has also partnered with National Development on the repositioning of the Necco Street garage as well as GE’s would-be headquarters at Innovation Point. Add in Related Beal’s purchase of surface lots from Gillette, and nearly $600 million has been invested in land deals to turn this area into the next life science hub.

Demonstrating expertise in life science/lab development, Alexandria has also been instrumental in the transformation of Kendall Square, while Related Beal is underway on iSQ and the conversion of 451 D Street.

The A Street Corridor, served by both South Station and the Broadway T stop on the Red Line, also directly connects to Cambridge’s thriving Kendall Square. National Development has also been a buyer along Dorchester Avenue, furthering the potential for the life science market to expand around the Broadway stop. Widett Circle, while cut off today, could also be a future area of lab growth in the years to come. Sites owned nearby by the Postal Service have long been coveted by market players and could become available in time. But with a cluster forming across the street by Gillette and GE, it is not far-fetched to think that life science will be a focus.

Heavy hitters are active in the area, and it won’t be long before other property holders start to think about converting or selling. It’s still early, but the A Street Corridor is looking like a strong bet to emerge as the area’s next hot spot for life science. 


Subscribe to Colliers In Focus Blog Posts